HZNP Horizon Therapeutics Public Limited Company

25.95
+0.61  (+2%)
Previous Close 25.34
Open 25.36
Price To Book 3.19
Market Cap 4797736712
Shares 184,883,881
Volume 1,378,581
Short Ratio
Av. Daily Volume 1,464,015

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data released December 8, 2016 - primary endpoint not met.
ACTIMMUNE
Friedreich's Ataxia (FA)
BLA filing due mid-2019.
Teprotumumab
Thyroid Eye Disease (TED)
Phase 2 trial initiation announced September 27, 2018.
Krystexxa with Methotrexate
Gout

Latest News

  1. Horizon Named One of the Best Workplaces in Chicago by Great Place to Work® and FORTUNE
  2. Horizon Therapeutics plc Launches New Data-Driven Campaign to Reset the Dialogue on Gout
  3. Edited Transcript of HZNP earnings conference call or presentation 8-May-19 12:00pm GMT
  4. Market Weekly Review: China Trade Dispute Hits Stocks
  5. Horizon Therapeutics' (HZNP) Q1 Earnings Beat Estimates
  6. Horizon Therapeutics plc Announces Tina Ventura as a Healthcare Businesswomen's Association 2019 Luminary
  7. Top-Rated Pharma Stock Nears Breakout After Earnings Trounce Views
  8. Here's How Horizon Therapeutics Blew Past Wall Street Estimates in Q1
  9. Horizon Pharma PLC (HZNP) Q1 2019 Earnings Call Transcript
  10. Horizon Pharma (HZNP) Q1 Earnings and Revenues Top Estimates
  11. Horizon Pharma: 1Q Earnings Snapshot
  12. Horizon Therapeutics plc Reports Strong First-Quarter 2019 Results; Increases Full‐Year 2019 Net Sales and Adjusted EBITDA Guidance
  13. RPT In Canada, a little-known drug regulator shows its teeth
  14. In Canada, a little-known drug regulator shows its teeth
  15. What's in Store for Axsome (AXSM) This Earnings Season?
  16. What's in the Cards for AcelRx (ACRX) This Earnings Season?
  17. Guardant Health (GH) to Report Q1 Earnings: What's in Store?
  18. Proteostasis (PTI) to Post Q1 Earnings: What's in Store?
  19. See what the IHS Markit Score report has to say about Horizon Pharma PLC.
  20. What's in Cards for Cumberland (CPIX) This Earnings Season?